miRNA‑155 expression and role in pathogenesis in spinal tuberculosis‑induced intervertebral disc destruction

Yang,Chengzhi; Shi,Zhanying; Hu,Juzheng; Wei,Renjie; Yue,Guoping; Zhou,Dan

doi:10.3892/etm.2019.7313

miRNA‑155 expression and role in pathogenesis in spinal tuberculosis‑induced intervertebral disc destruction

Authors:
- Chengzhi Yang
- Zhanying Shi
- Juzheng Hu
- Renjie Wei
- Guoping Yue
- Dan Zhou
View Affiliations

Affiliations: Trauma Center, Guangxi Liuzhou Workers Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi 545000, P.R. China, Department of Trauma Orthopedics, Hechi People's Hospital, Hechi, Guangxi 547000, P.R. China, Department of Joint Osteopathy, Guangxi Liuzhou Workers Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi 545000, P.R. China
Published online on: February 26, 2019 https://doi.org/10.3892/etm.2019.7313
Pages: 3239-3246
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The current study aimed to investigate microRNA‑155 (miR‑155) expression in spinal tuberculosis‑induced intervertebral disc destruction and its regulatory role in disease pathogenesis. A total of 26 patients with intervertebral disc destruction induced by spinal tuberculosis and 31 healthy individuals were included. Reverse transcription‑quantitative polymerase chain reactions, western blot analysis and ELISA were performed to detect mRNA and protein expression levels. A bioinformatics analysis was applied to predict the upstream regulator of matrix metalloproteinase (MMP)13, which was confirmed by dual‑luciferase reporter assay. Compared with the control group, mRNA and protein expression levels of MMP13 were significantly increased in the intervertebral disc of patients with spinal tuberculosis. However, miR‑155 expression in the intervertebral disc of patients with spinal tuberculosis was significantly decreased compared with the control group. Dual‑luciferase reporter assays suggested that miR‑155 bound to the 3'‑untranslated region of MMP13 to regulate gene expression. In primary annulus fibrosus cells, upregulated miR‑155 expression significantly decreased MMP13 expression in the cells and culture supernatant, whereas it increased type II collagen expression. Upregulated MMP13 expression in the intervertebral disc in patients with spinal tuberculosis may be correlated with downregulated miR‑155 expression. miR‑155 may regulate expression levels of associated proteins in the intervertebral disc via modulating MMP13 expression, which contributes to the disease pathogenesis. The results of the current study may provide the theoretical basis for the diagnosis and treatment of disc damages caused by spinal tuberculosis.

View Figures

View References

1	Wang Y, Wang Q, Zhu R, Yang C, Chen Z, Bai Y, Li M and Zhai X: Trends of spinal tuberculosis research (1994-2015): A bibliometric study. Medicine (Baltimore). 95:e49232016. View Article : Google Scholar : PubMed/NCBI
2	Wang XW, Liu JJ, Wu QN, Wu SF and Hao DJ: The in vitro and in vivo effects of microRNA-133a on intervertebral disc destruction by targeting MMP9 in spinal tuberculosis. Life Sci. 188:198–205. 2017. View Article : Google Scholar : PubMed/NCBI
3	Tsarouhas A, Soufla G, Katonis P, Pasku D, Vakis A and Spandidos DA: Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with lumbar disc herniation. Eur Spine J. 20:781–790. 2011. View Article : Google Scholar : PubMed/NCBI
4	Xiong C, Zhan X and Xiao Z: Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with tuberculous intervertebral discs and healthy controls. Clin Biochem. 46:603–611. 2013. View Article : Google Scholar : PubMed/NCBI
5	Bonnans C, Chou J and Werb Z: Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 15:786–801. 2014. View Article : Google Scholar : PubMed/NCBI
6	Roughley PJ, Geng Y and Mort JS: The non-aggregated aggrecan in the human intervertebral disc can arise by a non-proteolytic mechanism. Eur Cell Mater. 28:129–136. 2014. View Article : Google Scholar : PubMed/NCBI
7	Wang SZ, Rui YF, Lu J and Wang C: Cell and molecular biology of intervertebral disc degeneration: Current understanding and implications for potential therapeutic strategies. Cell Prolif. 47:381–390. 2014. View Article : Google Scholar : PubMed/NCBI
8	Wang J, Ma J, Gu JH, Wang FY, Shang XS, Tao HR and Wang X: Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1β is mediated by curcumin via inhibition of NF-κB signaling in rat chondrocytes. Mol Med Rep. 16:1837–1845. 2017. View Article : Google Scholar : PubMed/NCBI
9	Guo Y, Li W, Qin J, Lu C and Fan W: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells. J Med Virol. 89:1274–1280. 2017. View Article : Google Scholar : PubMed/NCBI
10	Schneider A, Victoria B, Lopez YN, Suchorska W, Barczak W, Sobecka A, Golusinski W, Masternak MM and Golusinski P: Tissue and serum microRNA profile of oral squamous cell carcinoma patients. Sci Rep. 8:6752018. View Article : Google Scholar : PubMed/NCBI
11	Eleme K, Taner SB, Onfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI and Davis DM: Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J Exp Med. 199:1005–1010. 2004. View Article : Google Scholar : PubMed/NCBI
12	Iliopoulos D, Kavousanaki M, Ioannou M, Boumpas D and Verginis P: The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur J Immunol. 41:1754–1763. 2011. View Article : Google Scholar : PubMed/NCBI
13	Bird L: Immune regulation: MicroRNAs keep microglia quiet. Nat Rev Immunol. 11:762011. View Article : Google Scholar : PubMed/NCBI
14	Amin I, Patil BL, Briddon RW, Mansoor S and Fauquet CM: A common set of developmental miRNAs are upregulated in Nicotiana benthamiana by diverse begomoviruses. Virol J. 8:1432011. View Article : Google Scholar : PubMed/NCBI
15	Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Böttger T, et al: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 13:434–446. 2011. View Article : Google Scholar : PubMed/NCBI
16	Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S and Croce CM: Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci USA. 108:4908–4913. 2011. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Chen X, Gu S, Chen BF, Shen WL, Yin Z, Xu GW, Hu JJ, Zhu T, Li G, Wan C, et al: Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway. Biomaterials. 53:239–250. 2015. View Article : Google Scholar : PubMed/NCBI
19	Specchia N, Pagnotta A, Toesca A and Greco F: Cytokines and growth factors in the protruded intervertebral disc of the lumbar spine. Eur Spine J. 11:145–151. 2002. View Article : Google Scholar : PubMed/NCBI
20	Cauci S, Viganò M, de Girolamo L, De Luca P, Perucca Orfei C, Banfi G, Lombardi G, Brayda-Bruno M and Colombini A: High levels of circulating type II collagen degradation marker (CTx-II) are associated with specific VDR polymorphisms in patients with adult vertebral osteochondrosis. Int J Mol Sci. 18:E20732017. View Article : Google Scholar : PubMed/NCBI
21	Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA and Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 55:91–97. 2002. View Article : Google Scholar : PubMed/NCBI
22	Loreto C, Leonardi R, Musumeci G, Pannone G and Castorina S: An ex vivo study on immunohistochemical localization of MMP-7 and MMP-9 in temporomandibular joint discs with internal derangement. Eur J Histochem. 57:e122013. View Article : Google Scholar : PubMed/NCBI
23	Loreto C, Musumeci G, Castorina A, Loreto C and Martinez G: Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death. Ann Anat. 193:156–62. 2011. View Article : Google Scholar : PubMed/NCBI
24	Anderson DG, Izzo MW, Hall DJ, Vaccaro AR, Hilibrand A, Arnold W, Tuan RS and Albert TJ: Comparative gene expression profiling of normal and degenerative discs: Analysis of a rabbit annular laceration model. Spine (Phila Pa 1976). 27:1291–1296. 2002. View Article : Google Scholar : PubMed/NCBI
25	Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC and Eisenstein SM: Matrix metalloproteinases and aggrecanase: Their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976). 25:3005–3013. 2000. View Article : Google Scholar : PubMed/NCBI
26	Inukai S, Pincus Z, de Lencastre A and Slack FJ: A microRNA feedback loop regulates global microRNA abundance during aging. RNA. 24:159–172. 2018. View Article : Google Scholar : PubMed/NCBI
27	Williams AE, Moschos SA, Perry MM, Barnes PJ and Lindsay MA: Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn. 236:572–580. 2007. View Article : Google Scholar : PubMed/NCBI
28	Leonardi R, Loreto C, Barbato E, Caltabiano R, Lombardo C, Musumeci G and Lo Muzio L: MMP-13 (collagenase 3) localization in human temporomandibular joint discs with internal derangement. Acta Histochem. 110:314–318. 2008. View Article : Google Scholar : PubMed/NCBI
29	Paliouras AR, Monteverde T and Garofalo M: Oncogene-induced regulation of microRNA expression: Implications for cancer initiation, progression and therapy. Cancer Lett. 421:152–160. 2018. View Article : Google Scholar : PubMed/NCBI
30	Lv ZC, Fan YS, Chen HB and Zhao DW: Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. Tumour Biol. 36:1619–1625. 2015. View Article : Google Scholar : PubMed/NCBI
31	Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis D, Jia LT, Wu SX, Huang J, Chen J and Luo ZJ: Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol. 225:232–242. 2011. View Article : Google Scholar : PubMed/NCBI
32	Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K and Jacob ST: Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology. 50:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
33	Martin EC, Krebs AE, Burks HE, Elliott S, Baddoo M, Collins-Burow BM, Flemington EK and Burow ME: miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling. Genes Cancer. 5:353–364. 2014.PubMed/NCBI
34	Louafi F, Martinez-Nunez RT and Sanchez-Elsner T: MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem. 285:41328–41336. 2010. View Article : Google Scholar : PubMed/NCBI